首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1276223

药物输送市场——按给药途径、应用、使用设施分类——到 2032 年的全球预测

Pharmaceutical Drug Delivery Market - By Route Of Administration, By Application, Facility Of Use - Global Forecast to 2032

出版日期: 2023年04月21日 | 出版商:

Global Market Insights Inc. | 英文 850 Pages | 商品交期: 2-3个工作天内

价格

简介目录

到 2032 年，全球药物输送市场规模将显着增长。

糖尿病、心血管疾病和关节炎等慢性病的激增导致死亡率上升。据世界卫生组织称，心血管疾病每年在全世界造成约 1790 万人死亡。为此，许多医疗机构和製药公司都在大力投资提高药效和给药途径，行业发展潜力巨大。

整个药物给药市场细分为应用、给药途径、使用设施和区域。

就给药途径而言，到 2032 年，口服给药的市场规模将显着增长。传染病、炎症性疾病和胃肠道疾病的流行增加了对口服给药的需求。而且，这种给药途径成本低廉，对老人和儿童也很方便。

按应用来看，到 2032 年，肿瘤药物给药市场预计将增长 8.5% 以上。癌症患病率的增加增加了对引入新的药物给药方法的投资。此外，全球许多製药公司和医疗机构都在大力投资癌症研究，这也有望对该领域的扩张产生积极影响。例如，2023年3月，美国跨国製药公司辉瑞公司宣布将投资超过430亿美元用于癌症研究。

根据使用设施，该行业分为门诊手术中心和诊所、医院、家庭护理机构、诊断中心和其他使用设施。从 2023 年到 2032 年，按家庭护理环境划分的药物输送行业预计将以超过 7.5% 的复合年增长率增长。不断增长的老年人口和慢性病的流行将支持这一细分市场的增长。此外，家庭保健具有成本效益，正在被采用。

按地区划分，亚太地区的药物输送行业预计从 2023 年到 2032 年将以显着的复合年增长率增长。行业参与者增加对产品创新研发的投资有助于该地区的增长。此外，几个区域经济体的政府也在大力投资扩大医疗保健基础设施，这将进一步促进区域扩张。根据 Invest India 的数据，到 2030 年，印度的医疗保健行业可能达到 1880 亿美元。

内容

第一章调查方法及范围

第 2 章执行摘要

第 3 章药物给药市场洞察

行业细分
2018-2032 年行业格局
影响行业的因素
- 司机
  - 慢性病患病率上升
  - 生物製品市场的增长
  - 技术进步和新产品发布
  - 扩大对医药研发的投资
  - 自我管理和家庭护理
- 行业潜在的风险和挑战
  - 针刺伤的风险

昂贵的药物开发过程

增长潜力分析
- 按给药途径
- 通过使用
- 按设施
COVID-19 影响分析
监管状况
波特分析
PESTLE 分析

第 4 章竞争格局，2022 年

简介
公司矩阵分析，2022 年
2022 年竞争对手定位矩阵
公司股票分析，2022 年
战略愿景矩阵，2022 年
战略仪表板，2022 年

第 5 章药物给药市场：按给药途径

主要细分市场的趋势
口服给药
- 固体口服药
  - 药片
  - 胶囊
  - 粉末
  - 药片
- 液体口服製剂
  - 糖浆
  - 解决方案
- 半固体口服药物
  - 凝胶
  - 乳液
  - 长生不老药
注射给药
- 常规注射器
  - 按材料
    - 玻璃注射器
    - 塑料注射器
  - 按产品分类
    - 可填充注射器
    - 预装注射器
  - 使用感受
    - 可重复使用的注射器
    - 一次性注射器
- 自动注射器
  - 无针注射器
  - 自动注射器
  - 注射笔
  - 可穿戴注射器
- 其他注射器
本地药物输送
- 液体製剂
  - 解决方案
  - 暂停
- 半固体製剂
  - 奶油色
  - 凝胶
  - 药膏
  - 粘贴
  - 乳液
- 固体製剂
  - 压疮
  - 粉末
- 透皮製剂
  - 透皮贴剂
  - 透皮凝胶
眼科药物输送
- 液体製剂
  - 眼药水
  - 喷液
- 半固体製剂
  - 凝胶
  - 眼药膏
- 眼科设备
  - 药物涂层隐形眼镜
  - 眼科插入物
呼吸药物输送
- 固定剂量吸入器
- 干粉吸入器
- 雾化器
  - 喷射雾化器
  - 超声波雾化器
  - 软雾雾化器
鼻腔给药
- 滴鼻剂
- 滴鼻剂
- 粉末
- 鼻用凝胶
经粘膜给药
- 口服配方
  - 颊侧分娩
  - 舌下给药
- 其他口服给药技术
  - 直肠分娩
  - 阴道内给药
植入式给药
- 主动移植
- 被动植入药物输送

第 6 章药物给药市场：按应用

主要细分市场的趋势
感染
癌症
心血管疾病
糖尿病
呼吸系统疾病
中枢神经系统疾病
自身免疫性疾病
其他用途

第 7 章药物给药市场：按设施

主要细分市场的趋势
医院
门诊手术中心/诊所
家庭医疗机构
诊断中心
用于其他目的的设施

第 8 章药物给药市场：按地区划分的趋势

主要区域趋势
北美
- 美国
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 意大利
- 瑞士
- 其他欧洲
亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 墨西哥
- 其他拉丁美洲地区
中东和非洲
- 南非
- 沙特阿拉伯
- 其他中东和非洲地区

第九章公司简介

Pfizer Inc.
Johnson & Johnson
AbbVie Inc.
Merck & Co., Inc.
Sanofi
Bayer AG
Amgen, Inc
AstraZeneca plc
Eli Lilly and Company
Gilead Science, Inc.

简介目录

Product Code: 5565

Global Pharmaceutical Drug Delivery Market size will garner commendable gains through 2032. Surging incidences of chronic diseases such as diabetes, cardiovascular diseases, and arthritis have resulted in increased mortality rates. As per WHO, cardiovascular diseases account for around 17.9 million deaths every year globally. In this regard, many healthcare organizations and pharmaceutical companies are investing notable amounts to boost the efficacy of the medication and its route of administration, creating a broad scope for industry growth.

The overall pharmaceutical drug delivery market is classified into application, route of administration, facility of use, and region.

With respect to the route of administration, the industry share from the oral drug delivery market size will register recognizable growth through 2032. Rising prevalence of infectious, inflammatory, gastrointestinal diseases, and others has increased the demand for oral administration. Moreover, this route of drug administration is also cost-effective and convenient for the elderly and children.

Based on application, the pharmaceutical drug delivery market from the cancer segment will grow at over 8.5% by 2032. Increasing incidences of cancer have increased investments in introducing new pharmaceutical drug delivery methods. Many pharmaceutical companies and healthcare organizations across the globe are investing substantial amounts into cancer research which will also positively affect segment expansion. To illustrate, in March 2023, Pfizer Inc., an American multinational pharmaceutical company, announced over USD 43 billion in cancer research.

Based on the facility of use, the industry is classified into ambulatory surgical centers and clinics, hospitals, home care settings, diagnostic centers, and other facilities of use. The pharmaceutical drug delivery industry from the home care settings segment will grow at more than 7.5% CAGR from 2023 to 2032. Growing geriatric population base and its susceptibility to chronic diseases will support segment growth. Additionally, the high cost-effectiveness of home care settings favors their adoption.

On the regional front, the Asia Pacific pharmaceutical drug delivery industry share will grow at a substantial CAGR from 2023 to 2032. Growing R&D investments by industry players in product innovations are contributing to regional growth. Moreover, the governments across several regional economies are also investing significant amounts into expanding the healthcare infrastructure, which will further work towards regional expansion. As per Invest India, the healthcare industry in India has the potential to reach USD 188 billion by 2030.

Chapter 1 Methodology & Scope

1.1 Industry coverage
1.2 Market scope and definitions
1.3 Base estimates and working
- 1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
- 1.7.1 Primary
- 1.7.2 Secondary
  - 1.7.2.1 Paid sources
  - 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Pharmaceutical drug delivery industry 360 degree synopsis, 2018 - 2032
2.2 Business trends
2.3 Route of administration trends
2.4 Application trends
2.5 Facility of use trends
2.6 Regional trends

Chapter 3 Pharmaceutical Drug Delivery Market Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Rising prevalence of chronic diseases
  - 3.3.1.2 Growth in the biologics market
  - 3.3.1.3 Technological advancement and new product launches
  - 3.3.1.4 Increasing investment in pharmaceutical R&D
  - 3.3.1.5 Self-administration and home care
- 3.3.2 Industry pitfalls & challenges
  - 3.3.2.1 Risk of needlestick injuries

.3.3.2.2. Cost intensive drug development process

3.4 Growth potential analysis
- 3.4.1 By route of administration
- 3.4.2 By application
- 3.4.3 By facility of use
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTLE Analysis

Chapter 4 Competitive landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Company market share analysis, 2022
4.5 Strategic outlook matrix, 2022
4.6 Strategy dashboard, 2022

Chapter 5 Pharmaceutical Drug Delivery Market, By Route of Administration

5.1 Key segment trends
5.2 Oral drug delivery
- 5.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.2 Solid oral drugs
  - 5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.2 Tablets
    - 5.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.3 Capsules
    - 5.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.4 Powder
    - 5.2.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.2.5 Pills
    - 5.2.2.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.3 Liquid oral drugs
  - 5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.2 Syrups
    - 5.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.3.3 Solutions
    - 5.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.2.4 Semi-solid oral drugs
  - 5.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.2 Gels
    - 5.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.3 Emulsions
    - 5.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.2.4.4 Elixirs
    - 5.2.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.3 Injectable drug delivery
- 5.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.2 Conventional injection devices
  - 5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.2 By material
    - 5.3.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.2 Glass syringes
    - 5.3.2.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.2.3 Plastic syringes
    - 5.3.2.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.3 By product
    - 5.3.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.2 Fillable syringes
    - 5.3.2.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.3.3 Prefilled syringes
    - 5.3.2.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.2.4 By usability
    - 5.3.2.4.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.2 Reusable syringes
    - 5.3.2.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
    - 5.3.2.4.3 Disposable syringes
    - 5.3.2.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.3 Self-injection devices
  - 5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.2 Needle-free injectors
    - 5.3.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.3 Autoinjectors
    - 5.3.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.4 Pen injectors
    - 5.3.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.3.3.5 Wearable injectors
    - 5.3.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.3.4 Other injector devices
  - 5.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.4 Topical drug delivery
- 5.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.2 Liquid formulations
  - 5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.2 Solutions
    - 5.4.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.2.3 Suspensions
    - 5.4.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.3 Semi-solid formulations
  - 5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.2 Creams
    - 5.4.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.3 Gels
    - 5.4.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.4 Ointments
    - 5.4.3.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.5 Pastes
    - 5.4.3.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.3.6 Lotions
    - 5.4.3.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.4 Solid formulations
  - 5.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.2 Suppositories
    - 5.4.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.4.3 Powders
    - 5.4.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.4.5 Transdermal products
  - 5.4.5.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.2 Transdermal patches
    - 5.4.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.4.5.3 Transdermal gels
    - 5.4.5.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.5 Ocular drug delivery
- 5.5.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.2 Liquid formulations
  - 5.5.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.2 Eye drops
    - 5.5.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.2.3 Liquid sprays
    - 5.5.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.3 Semi-solid formulations
  - 5.5.3.2 Gels
    - 5.5.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.3.3 Eye ointments
    - 5.5.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.5.4 Ocular devices
  - 5.5.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.2 Drug-coated contact lenses
    - 5.5.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.5.4.3 Ocular inserts
    - 5.5.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.6 Pulmonary drug delivery
- 5.6.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.2 Metered-dose inhalers
  - 5.6.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.3 Dry powder inhalers
  - 5.6.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.6.4 Nebulizers
  - 5.6.4.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.2 Jet nebulizers
    - 5.6.4.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.3 Ultrasonic nebulizers
    - 5.6.4.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.6.4.4 Soft mist nebulizers
    - 5.6.4.4.1 Market size, by region, 2018 - 2032 (USD Million)
5.7 Nasal drug delivery
- 5.7.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.2 Nasal drops
  - 5.7.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.3 Nasal sprays
  - 5.7.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.4 Nasal powders
  - 5.7.4.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.7.5 Nasal gels
  - 5.7.5.1 Market size, by region, 2018 - 2032 (USD Million)
5.8 Transmucosal drug delivery
- 5.8.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.2 Oral formulations
  - 5.8.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.2 Buccal drug delivery
    - 5.8.2.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.2.3 Sublingual drug delivery
    - 5.8.2.3.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.8.3 Other transmucosal drug delivery technologies
  - 5.8.3.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.2 Rectal drug delivery
    - 5.8.3.2.1 Market size, by region, 2018 - 2032 (USD Million)
  - 5.8.3.3 Vaginal drug delivery
    - 5.8.3.3.1 Market size, by region, 2018 - 2032 (USD Million)
5.9 Implantable drug delivery
- 5.9.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.2 Active implantable drug delivery
  - 5.9.2.1 Market size, by region, 2018 - 2032 (USD Million)
- 5.9.3 Passive implantable drug delivery
  - 5.9.3.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 6 Pharmaceutical Drug Delivery Market, By Application

6.1 Key segment trends
6.2 Infectious diseases
- 6.2.1 Market size, by region, 2018 - 2032 (USD Million)
6.3 Cancer
- 6.3.1 Market size, by region, 2018 - 2032 (USD Million)
6.4 Cardiovascular diseases
- 6.4.1 Market size, by region, 2018 - 2032 (USD Million)
6.5 Diabetes
- 6.5.1 Market size, by region, 2018 - 2032 (USD Million)
6.6 Respiratory diseases
- 6.6.1 Market size, by region, 2018 - 2032 (USD Million)
6.7 Central nervous system disorders
- 6.7.1 Market size, by region, 2018 - 2032 (USD Million)
6.8 Autoimmune diseases
- 6.8.1 Market size, by region, 2018 - 2032 (USD Million)
6.9 Other applications
- 6.9.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 7 Pharmaceutical Drug Delivery Market, By Facility of Use

7.1 Key segment trends
7.2 Hospitals
- 7.2.1 Market size, by region, 2018 - 2032 (USD Million)
7.3 Ambulatory surgical centers and clinics
- 7.3.1 Market size, by region, 2018 - 2032 (USD Million)
7.4 Home care settings
- 7.4.1 Market size, by region, 2018 - 2032 (USD Million)
7.5 Diagnostic centers
- 7.5.1 Market size, by region, 2018 - 2032 (USD Million)
7.6 Other facilities of use
- 7.6.1 Market size, by region, 2018 - 2032 (USD Million)

Chapter 8 Pharmaceutical Drug Delivery Market, By Region

8.1 Key regional trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Switzerland
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East & Africa